A first-in-human trial to evaluate safety, tolerability, and pharmacokinetics of single and multiple oral doses of Debio 1453P in healthy adults
Debio 1453-101
Phase 1 other active
Quick answer
A first-in-human trial to evaluate safety, tolerability, and pharmacokinetics of single and multiple oral doses of Debio 1453P in healthy adults for Sexual Transmitted Infection (STI) is a Phase 1 program (other) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Sexual Transmitted Infection (STI)
- Phase
- Phase 1
- Modality
- other
- Status
- active